Aytu Biopharma Inc stock is traded at $2.66, with a volume of 1,664,261. It is up +46.23% in the last 24 hours and up +30.46% over the past month. Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Previous Close:
$1.82
Open:
$2.66
24h Volume:
1,664,261
Relative Volume:
9.64
Market Cap:
$28.92M
Revenue:
$56.60M
Net Income/Loss:
-$34.12M
P/E Ratio:
-
EPS:
-$4.58
Net Cash Flow:
-$1.36M
1W Performance:
+47.04%
1M Performance:
+30.46%
6M Performance:
+21.53%
1Y Performance:
+34.41%
1-Day Range:
$2.66$2.67
1-Week Range:
$1.75$2.67
52-Week Range:
$1.75$3.07
Aytu Biopharma Inc Stock (AYTU) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS